BioStorage Technologies' Frankfurt facility receives green certification from ENTEGA Vertrieb

BioStorage Technologies, a worldwide provider of long- and short-term storage of biomaterials, sample management and cold chain logistics, today announced its full-service biorepository near Frankfurt, Germany received green certification from ENTEGA Vertrieb GmbH & Co., a leading Germany-based sustainable energy supplier.

Serving global pharmaceutical and biotech firms, donor organizations and biobanks as well as research and academic organizations, BioStorage Technologies' 18,000 square-foot (1,672 square-meter) biorepository, uses an estimated 360,000-kilowatt hours (kWh) of power per year. By using 100 percent renewable energy, BioStorage Technologies is preventing the generation of an estimated 189 tons of environmentally harmful carbon dioxide (CO2) in the first year, thus making a valuable contribution to environmental protection. As the European operation grows, the amount of carbon dioxide prevented from generation will increase significantly.

"We are pleased to have all of our global facilities operating with 100 percent renewable energy," said F. John Mills, M.D., Ph.D., chairman and chief executive officer at BioStorage Technologies. "This initiative demonstrates our commitment to conserving energy and improving the health of the environment by decreasing carbon dioxide emissions."

Dr. Wolfgang Hoffer, managing director of BioStorage Technologies' European operations, adds, "Using renewable energy is only one of the green initiatives underway at our facilities. Additional aspects of the initiative include environmentally conscious management of waste disposal, logistics, water consumption and paper use."

BioStorage Technologies is also researching low VOC (Volatile Organic Compound) cleaning agents, the use of fair-trade products where applicable and other ways of making facilities and services better for the overall health of individuals and the environment.

SOURCE BioStorage Technologies, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows how a single defective BRCA1 gene accelerates cancer development